Literature DB >> 34011402

Arylated gold nanoparticles have no effect on the adipogenic differentiation of MG-63 cells nor regulate any key signaling pathway during the differentiation.

Muhammad Abdulwahab1, Amir Ali Khan2,3, Sallam Hasan Abdallah4, Muhammad Nasir Khan Khattak1,4, Bizuneh Workie5, Mohamed Mehdi Chehimi6, Ahmed Ali Mohamed7.   

Abstract

OBJECTIVE: MG-63 cells that have osteoblastic and adipogenic differentiation potential were evaluated for internalization, and adipogenic differentiation in the presence and absence of the covalently functionalized aryl gold nanoparticles (AuNPs-C6H4-4-COOH).
RESULTS: Inductively coupled plasma, flow cytometry and confocal microscopy analyses confirmed that gold nanoparticles were easily internalized by MG-63 cells. The MG-63 cells were differentiated into adipocytes without gold-aryl nanoparticles and with the gold-aryl nanoparticles at 5 µM concentration in both induction and maintenance media. The lipid content assay and the relative expressions of PPAR-γ, ADR1, GLUT1 and GLUT4 genes showed no significant variation with and without the gold nanoparticles treatment. Differential phosphorylation levels of 43 kinases phosphorylation sites were evaluated using the human phospho-kinase array to assess the effect of the gold nanoparticles on the signaling pathways during the differentiation. No kinase phosphorylation site was differentially phosphorylated with two or more folds after the nanoparticles treatment after the first day as well as at the end of MG-63 cells differentiation. The gold-aryl nanoparticles do not affect MG-63 cells differentiation into adipocytes neither do they affect any key signaling pathway. These properties make these gold nanoparticles suitable for future drug delivery and medical applications.

Entities:  

Keywords:  Adipogenic differentiation; Gold-aryl nanoparticles; Signaling pathways; Stem cells

Year:  2021        PMID: 34011402     DOI: 10.1186/s13104-021-05594-9

Source DB:  PubMed          Journal:  BMC Res Notes        ISSN: 1756-0500


  1 in total

1.  Different combinations of monoclonal antibodies and polyclonal antibodies in the design of neonatal hypothyroidism diagnostic kit.

Authors:  Neda Shakerian; Maysam Mard-Soltani; Sima Nasri; Mohammad Javad Rasaee; Saeed Khalili
Journal:  Appl Biochem Biotechnol       Date:  2022-03-29       Impact factor: 3.094

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.